Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solaraze 3-month versus 6-month treatment for actinic keratosis of face and scalp
2004-002761-21Phase 4Active
- Sponsor
- University Medical Center of Southern Nevada
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of diclofenac in actinic keratosis (AK) (2 arms), sponsored by University Medical Center of Southern Nevada. Started Nov 2005; status: active.
02
Drugs
diclofenac
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2004-002761-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002761-21.